| abstract |
The invention concerns a novel gene, coding for a protein named Erbin (Erbb2 Interacting protein), which interacts with the intracellular part of ERBB2/HER-2 receptors, involved in particular in the development of cancers, the diagnostic and therapeutic uses of novel nucleotide sequences and identified amino acids. |